BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


AMAG Pharmaceuticals, Inc. 

1100 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-498–3300 Fax: 617-499-3361


Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.

AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.

 Key Statistics

Ownership: Public

Web Site: AMAG Pharmaceuticals, Inc.
Employees: 51-200
Symbol: AMAG


 Company News
AMAG Pharmaceuticals, Inc. (AMAG) Expands Resources Dedicated To Reducing The Risk Of Preterm Birth 5/20/2015 8:19:26 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The UBS Global Healthcare Conference 5/14/2015 10:32:28 AM
AMAG Pharmaceuticals, Inc. (AMAG) Reports Record First Quarter 2015 Financial Results And Increases Financial Guidance 5/5/2015 10:10:44 AM
AMAG Pharmaceuticals, Inc. (AMAG)To Present At Upcoming Investor Conferences 4/30/2015 11:06:13 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Host Conference Call On May 5, 2015 At 8:00 A.M. ET To Discuss Financial Results For The Quarter Ended March 31, 2015 4/23/2015 10:38:09 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The 14th Annual Needham Healthcare Conference 4/8/2015 8:16:40 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces New Management Appointments 4/2/2015 7:10:37 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Closing Of $201 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option 3/4/2015 7:07:16 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The Cowen and Company 35th Annual Healthcare Conference 2/27/2015 7:21:28 AM
AMAG Pharmaceuticals, Inc. (AMAG) Prices Public Offering Of $175 Million Of Common Stock 2/26/2015 6:20:32 AM